• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing the Collective Population Representativeness of Related Type 2 Diabetes Trials by Combining Public Data from ClinicalTrials.gov and NHANES.通过整合ClinicalTrials.gov和美国国家健康与营养检查调查(NHANES)的公共数据评估2型糖尿病相关试验的总体人群代表性
Stud Health Technol Inform. 2015;216:569-73.
2
[Integration of secondary data into national diabetes surveillance : Background, aims and results of the secondary data workshop at the Robert Koch Institute].[将二次数据整合到国家糖尿病监测中:罗伯特·科赫研究所二次数据研讨会的背景、目标和结果]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jun;60(6):656-661. doi: 10.1007/s00103-017-2552-7.
3
Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.基于索赔的口服降血糖药物研究仅能在电子健康记录中观察到关键临床变量的平衡。
Diabetes Obes Metab. 2018 Apr;20(4):974-984. doi: 10.1111/dom.13184. Epub 2018 Jan 12.
4
Electronic Health Record Data Versus the National Health and Nutrition Examination Survey (NHANES): A Comparison of Overweight and Obesity Rates.电子健康记录数据与国家健康和营养检查调查(NHANES):超重和肥胖率的比较
Med Care. 2017 Jun;55(6):598-605. doi: 10.1097/MLR.0000000000000693.
5
Integrating population- and patient-level data for secondary use of electronic health records to study overweight and obesity.整合人群和患者层面的数据以二次利用电子健康记录来研究超重和肥胖。
Stud Health Technol Inform. 2013;192:1100.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.比较临床试验人群代表性与真实世界人群:一项涵盖英国989种独特药物和286种病症的43895项试验及5685738名个体的外部有效性分析。
Lancet Healthy Longev. 2022 Oct;3(10):e674-e689. doi: 10.1016/S2666-7568(22)00186-6. Epub 2022 Sep 20.
8
Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.分析与索赔数据相关联的纵向电子健康记录以研究药物有效性和安全性的注意事项。
Clin Pharmacol Ther. 2016 Aug;100(2):147-59. doi: 10.1002/cpt.359. Epub 2016 May 12.
9
Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data.基于临床试验数据验证的电子健康记录数据中提取的慢性阻塞性肺疾病加重发作期。
Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1369-1376. doi: 10.1002/pds.4883. Epub 2019 Aug 5.
10
Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: findings from the GE Centricity Electronic Medical Record database.美国肥胖症、II 型糖尿病、高脂血症和高血压的流行情况:来自 GE Centricity 电子病历数据库的研究结果。
Popul Health Manag. 2010 Jun;13(3):151-61. doi: 10.1089/pop.2009.0039.

引用本文的文献

1
Association Between Antidepressant Use and Hemoglobin A1c Levels in Adults With Comorbid Type 2 Diabetes Mellitus and Depression.2型糖尿病合并抑郁症成人患者中抗抑郁药使用与糖化血红蛋白水平之间的关联
Cureus. 2025 Jul 7;17(7):e87442. doi: 10.7759/cureus.87442. eCollection 2025 Jul.
2
A comparative study of pre-trained language models for named entity recognition in clinical trial eligibility criteria from multiple corpora.基于多语料库的临床试验资格标准中命名实体识别的预训练语言模型的比较研究。
BMC Med Inform Decis Mak. 2022 Sep 6;22(Suppl 3):235. doi: 10.1186/s12911-022-01967-7.
3
Assessing the use of prescription drugs and dietary supplements in obese respondents in the National Health and Nutrition Examination Survey.评估国家健康与营养调查中肥胖受访者的处方药和膳食补充剂使用情况。
PLoS One. 2022 Jun 3;17(6):e0269241. doi: 10.1371/journal.pone.0269241. eCollection 2022.
4
Identification of tools used to assess the external validity of randomized controlled trials in reviews: a systematic review of measurement properties.评价工具识别:系统综述中评估随机对照试验外部真实性的测量特性
BMC Med Res Methodol. 2022 Apr 6;22(1):100. doi: 10.1186/s12874-022-01561-5.
5
Dietary Intake and Representativeness of a Diverse College-Attending Population Compared with an Age-Matched US Population.饮食摄入与不同大学生群体的代表性与美国同年龄段人群的比较。
Nutrients. 2021 Oct 26;13(11):3810. doi: 10.3390/nu13113810.
6
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics.度拉糖肽与利拉鲁肽对2型糖尿病患者健康结局的真实世界观察性前瞻性研究(TROPHIES):设计与基线特征
Diabetes Ther. 2021 Jul;12(7):1929-1946. doi: 10.1007/s13300-021-01076-0. Epub 2021 Jun 7.
7
Reporting of demographic data and representativeness in machine learning models using electronic health records.利用电子健康记录报告机器学习模型中的人口统计学数据和代表性。
J Am Med Inform Assoc. 2020 Dec 9;27(12):1878-1884. doi: 10.1093/jamia/ocaa164.
8
Assessing the Use and Perception of Dietary Supplements Among Obese Patients with National Health and Nutrition Examination Survey.通过国家健康与营养检查调查评估肥胖患者膳食补充剂的使用情况及认知。
AMIA Jt Summits Transl Sci Proc. 2020 May 30;2020:231-240. eCollection 2020.
9
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables.精准给药优先标准:药物、疾病及患者群体变量
Front Pharmacol. 2020 Apr 22;11:420. doi: 10.3389/fphar.2020.00420. eCollection 2020.
10
Comparing the Study Populations in Dietary Supplement and Drug Clinical Trials for Metabolic Syndrome and Related Disorders.比较膳食补充剂与药物治疗代谢综合征及相关疾病临床试验中的研究人群。
AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:799-808. eCollection 2019.

本文引用的文献

1
A method for analyzing commonalities in clinical trial target populations.一种分析临床试验目标人群共性的方法。
AMIA Annu Symp Proc. 2014 Nov 14;2014:1777-86. eCollection 2014.
2
Sharing and reporting the results of clinical trials.分享和报告临床试验结果。
JAMA. 2015 Jan 27;313(4):355-6. doi: 10.1001/jama.2014.10716.
3
National health and nutrition examination survey: analytic guidelines, 1999-2010.国家健康与营养检查调查:分析指南,1999 - 2010年
Vital Health Stat 2. 2013 Sep(161):1-24.
4
A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.一种基于分布的方法,用于评估电子健康记录中的临床试验目标人群和患者人群之间的差异。
Appl Clin Inform. 2014 May 7;5(2):463-79. doi: 10.4338/ACI-2013-12-RA-0105. eCollection 2014.
5
Hidden in plain sight: bias towards sick patients when sampling patients with sufficient electronic health record data for research.隐藏在明显之处:在为研究从电子健康记录数据充足的患者中抽样时,对患病患者的偏好。
BMC Med Inform Decis Mak. 2014 Jun 11;14:51. doi: 10.1186/1472-6947-14-51.
6
External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.试验中纳入了激素受体阳性的老年乳腺癌患者,其外部有效性。
J Natl Cancer Inst. 2014 Apr;106(4):dju051. doi: 10.1093/jnci/dju051. Epub 2014 Mar 19.
7
Clustering clinical trials with similar eligibility criteria features.对具有相似纳入标准特征的临床试验进行聚类。
J Biomed Inform. 2014 Dec;52:112-20. doi: 10.1016/j.jbi.2014.01.009. Epub 2014 Feb 1.
8
A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes.基于人群的、共享决策的方法招募 2 型糖尿病患者参加减肥手术与生活方式的随机试验。
Surg Obes Relat Dis. 2013 Nov-Dec;9(6):837-44. doi: 10.1016/j.soard.2013.05.006. Epub 2013 Jun 4.
9
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.美国国立卫生研究院资助的临床试验在 ClinicalTrials.gov 上的发表情况:横断面分析。
BMJ. 2012 Jan 3;344:d7292. doi: 10.1136/bmj.d7292.
10
Validating pathophysiological models of aging using clinical electronic medical records.使用临床电子病历验证衰老的病理生理学模型。
J Biomed Inform. 2010 Jun;43(3):358-64. doi: 10.1016/j.jbi.2009.11.007. Epub 2009 Dec 1.

通过整合ClinicalTrials.gov和美国国家健康与营养检查调查(NHANES)的公共数据评估2型糖尿病相关试验的总体人群代表性

Assessing the Collective Population Representativeness of Related Type 2 Diabetes Trials by Combining Public Data from ClinicalTrials.gov and NHANES.

作者信息

He Zhe, Wang Shuang, Borhanian Elhaam, Weng Chunhua

机构信息

Department of Biomedical Informatics, Columbia University, New York, NY, USA.

Department of Biostatistics, Columbia University, New York, NY, USA.

出版信息

Stud Health Technol Inform. 2015;216:569-73.

PMID:26262115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4586087/
Abstract

Randomized controlled trials generate high-quality medical evidence. However, the use of unjustified inclusion/exclusion criteria may compromise the external validity of a study. We have introduced a method to assess the population representativeness of related clinical trials using electronic health record (EHR) data. As EHR data may not perfectly represent the real-world patient population, in this work, we further validated the method and its results using the National Health and Nutrition Examination Survey (NHANES) data. We visualized and quantified the differences in the distributions of age, HbA1c, and BMI among the target population of Type 2 diabetes trials, diabetics in NHANES databases, and a convenience sample of patients enrolled in selected Type 2 diabetes trials. The results are consistent with the previous study.

摘要

随机对照试验能产生高质量的医学证据。然而,使用不合理的纳入/排除标准可能会损害研究的外部效度。我们引入了一种利用电子健康记录(EHR)数据评估相关临床试验人群代表性的方法。由于电子健康记录数据可能无法完美代表真实世界的患者群体,在这项研究中,我们使用美国国家健康与营养检查调查(NHANES)数据进一步验证了该方法及其结果。我们对2型糖尿病试验的目标人群、NHANES数据库中的糖尿病患者以及入选的2型糖尿病试验患者的便利样本之间的年龄、糖化血红蛋白(HbA1c)和体重指数(BMI)分布差异进行了可视化和量化。结果与之前的研究一致。